Dipeptidyl peptidase-IV inhibitors
4 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates generally to pyrrolidine and thiazolidine DPP-IV inhibitor compounds. The present invention also provides synthetic methods for preparation of such compounds, methods of inhibiting DPP-IV using such compounds and pharmaceutical formulations containing them for treatment of DPP-IV mediated diseases, in particular, Type-2 diabetes.
-
Citations
6 Claims
-
1. A compound according to the following formula:
-
2. A compound according to the following formula:
-
3. A pharmaceutical composition comprising a compound of the following formula:
-
4. A pharmaceutical composition comprising a compound of the following formula:
-
5. A method of treating type-2 diabetes comprising administering to a patient in need thereof an effective amount of a compound according to the following formula:
-
6. A method of treating type-2 diabetes comprising administering to a patient in need thereof an effective amount of a compound according to the following formula:
Specification